Aemetis Inc (NASDAQ: AMTX) has experienced a rise in its stock price by 932784 compared to its previous closing price of 2.04. However, the company has seen a gain of 7.01% in its stock price over the last five trading days. newsfilecorp.com reported 2025-06-16 that Dallas, Texas–(Newsfile Corp. – June 16, 2025) – Stonegate Capital Partners updates coverage on Aemetis, Inc. (Nasdaq: AMTX). In the first quarter of 2025, Aemetis reported total revenues of $42.9M, compared to $72.6M in the same period last year, with the year-over-year decline primarily driven by shifts in timing in receiving new government biodiesel contracts in India.
Is It Worth Investing in Aemetis Inc (NASDAQ: AMTX) Right Now?
AMTX has 36-month beta value of 1.49. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for AMTX is 50.35M, and currently, short sellers hold a 15.37% ratio of that float. The average trading volume of AMTX on June 25, 2025 was 933.55K shares.
AMTX’s Market Performance
The stock of Aemetis Inc (AMTX) has seen a 7.01% increase in the past week, with a 30.86% rise in the past month, and a 13.93% gain in the past quarter. The volatility ratio for the week is 8.23%, and the volatility levels for the past 30 days are at 5.28% for AMTX. The simple moving average for the past 20 days is 18.65% for AMTX’s stock, with a -2.04% simple moving average for the past 200 days.
Analysts’ Opinion of AMTX
Many brokerage firms have already submitted their reports for AMTX stocks, with UBS repeating the rating for AMTX by listing it as a “Buy.” The predicted price for AMTX in the upcoming period, according to UBS is $10.50 based on the research report published on August 16, 2023 of the previous year 2023.
Piper Sandler, on the other hand, stated in their research note that they expect to see AMTX reach a price target of $3. The rating they have provided for AMTX stocks is “Underweight” according to the report published on February 28th, 2023.
UBS gave a rating of “Neutral” to AMTX, setting the target price at $4.25 in the report published on December 14th of the previous year.
AMTX Trading at 39.43% from the 50-Day Moving Average
After a stumble in the market that brought AMTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.59% of loss for the given period.
Stock Fundamentals for AMTX
Current profitability levels for the company are sitting at:
- -0.2 for the present operating margin
- -0.02 for the gross margin
The net margin for Aemetis Inc stands at -0.37. The total capital return value is set at -0.68.
Based on Aemetis Inc (AMTX), the company’s capital structure generated 1.8 points at debt to capital in total, while cash flow to debt ratio is standing at -0.09. The debt to equity ratio resting at -2.25. The interest coverage ratio of the stock is -0.82.
Currently, EBITDA for the company is -37.13 million with net debt to EBITDA at -5.21. When we switch over and look at the enterprise to sales, we see a ratio of 1.53. The receivables turnover for the company is 228.08for trailing twelve months and the total asset turnover is 0.98. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.16.
Conclusion
To put it simply, Aemetis Inc (AMTX) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
